Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 936

1.

Clinical evidence and potential neurobiological underpinnings of unresolved symptoms of depression.

Trivedi MH, Hollander E, Nutt D, Blier P.

J Clin Psychiatry. 2008 Feb;69(2):246-58. Review.

PMID:
18363453
2.

The other face of depression, reduced positive affect: the role of catecholamines in causation and cure.

Nutt D, Demyttenaere K, Janka Z, Aarre T, Bourin M, Canonico PL, Carrasco JL, Stahl S.

J Psychopharmacol. 2007 Jul;21(5):461-71. Epub 2006 Oct 18. Review.

PMID:
17050654
4.

[Domino principle--monoamines in bottom-view].

Sümegi A.

Neuropsychopharmacol Hung. 2008 Jun;10(3):131-40. Review. Hungarian. Erratum in: Neuropsychopharmacol Hung. 2009 Sep;11(3):149.

5.
6.

Efficacy of newer medications for treating depression in primary care patients.

Mulrow CD, Williams JW Jr, Chiquette E, Aguilar C, Hitchcock-Noel P, Lee S, Cornell J, Stamm K.

Am J Med. 2000 Jan;108(1):54-64. Review.

PMID:
11059441
8.

Clinical and biochemical effects of catecholamine depletion on antidepressant-induced remission of depression.

Miller HL, Delgado PL, Salomon RM, Berman R, Krystal JH, Heninger GR, Charney DS.

Arch Gen Psychiatry. 1996 Feb;53(2):117-28.

PMID:
8629887
9.

Major depressive disorder: remission of associated symptoms.

Trivedi MH.

J Clin Psychiatry. 2006;67 Suppl 6:27-32. Review.

10.

Physical symptoms comorbid with depression and the new antidepressant duloxetine.

Bailey KP.

J Psychosoc Nurs Ment Health Serv. 2003 Dec;41(12):13-8. Review.

PMID:
14682027
11.

[Depression and pain: novel clinical, neurobiological and psychopharmacological data].

Jaracz J, Rybakowski J.

Psychiatr Pol. 2005 Sep-Oct;39(5):937-50. Review. Polish.

PMID:
16358593
12.

Differences in mechanism of action between current and future antidepressants.

Stahl SM, Grady MM.

J Clin Psychiatry. 2003;64 Suppl 13:13-7. Review.

13.

Switching antidepressants after a first selective serotonin reuptake inhibitor in major depressive disorder: a systematic review.

Ruhé HG, Huyser J, Swinkels JA, Schene AH.

J Clin Psychiatry. 2006 Dec;67(12):1836-55. Review.

PMID:
17194261
14.
15.

[Difficulties in the diagnosis and treatment of major depressive disorder with comorbid anxiety symptoms].

Akkaya C.

Turk Psikiyatri Derg. 2006 Summer;17(2):139-46. Review. Turkish.

16.

Desvenlafaxine succinate: a newer antidepressant for the treatment of depression and somatic symptoms.

Seo HJ, Sohi MS, Patkar AA, Masand PS, Pae CU.

Postgrad Med. 2010 Jan;122(1):125-38. doi: 10.3810/pgm.2010.01.2106. Review.

PMID:
20107296
17.

The effects of antidepressants on sleep: a review.

Gursky JT, Krahn LE.

Harv Rev Psychiatry. 2000 Dec;8(6):298-306. Review.

PMID:
11133824
18.

Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders.

Ressler KJ, Nemeroff CB.

Depress Anxiety. 2000;12 Suppl 1:2-19. Review.

PMID:
11098410
19.

[The effectiveness of antidepressants in the treatment of chronic non-cancer pain--a review].

Miller A, Rabe-Jabłońska J.

Psychiatr Pol. 2005 Jan-Feb;39(1):21-32. Review. Polish.

PMID:
15771151
20.

Supplemental Content

Support Center